Huons Global led South Korean consortium to produce Sputnik V Covid-19 vaccine
The consortium includes three other local companies- Prestige BioPharma, Humedix and Boran Pharma - which will build a new production facility, Huons said in a statement.
Advertisement
New Delhi: South Korea's Huons Global Co Ltd said on Friday it will lead a consortium to produce 100 million doses of Russia's Sputnik V Covid-19 vaccine per month as Moscow ramps up production for supplies abroad.
The announcement comes after South Korean biotech firm GL Rapha signed a deal with Russia's sovereign wealth fund late last year to make more than 150 million doses of Sputnik V per year.
Huons said the consortium will begin producing sample batches in August and respond flexibly to supply demands from the Russian Direct Investment Fund (RDIF).
The consortium includes three other local companies - Prestige BioPharma, Humedix and Boran Pharma - which will build a new production facility, Huons said in a statement.
Shares in Huons Global jumped 29.8% to their daily limit on Friday morning trade, versus a flat wider market.
India's ambassador to Moscow on Friday said deliveries of Russia's Sputnik V coronavirus vaccine to India were expected to begin before the end of April, after Indian regulators approved the shot for use on Monday.
The European Medicines Agency (EMA) is conducting a rolling review of the Russian vaccine as many European countries seek to ramp up inoculation programmes that have been hampered by delivery delays.
Read also: Dr Reddys working on Sputnik V stability data on 2 to 8 C temperature range
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.